Hematuria

Phase 4 trials (4)

• diclofenac
• conjugated equine estrogens
• acetylsalicylic acid
• bortezomib

Phase 3 trials (3)

• lidocaine
• furosemide
• isoprenaline

Phase 2 trials (2)

• finasteride
• tranexamic acid

Phase 1 trials (1)

• valproic acid

Other trials (4)

• praziquantel
• gentamicin
• cephalexin
• nitrofurantoin

Organization Involved with Phase 4 Indications (10)

• Pfizer
• Boston Urogynecology Associates
• Cornell University
• Harvard University
• Georgetown University
• The Rogosin Institute
• Istanbul Medeniyet University
• Tel Aviv University
• Mount Auburn Hospital
• Technion University

Organization Involved with Phase 3 Indications (2)

• Fredericia & Kolding Hospitals
• Fredericia Hospital

Organization Involved with Phase 2 Indications (6)

• Merck
• Fraser Health
• Aga Khan University
• University of British Columbia
• Health Canada
• Michael Smith Foundation for Health Research

Organization Involved with Phase 1 Indications (2)

• State University of New York
• State University of New York, Syracuse

Organization Involved with Other Experimental Indications (3)

• University of Copenhagen
• Hebrew University
• Durban University of Technology